Target type: molecularfunction
Binds to and stops, prevents or reduces the activity of an endopeptidase. [GOC:jl]
Endopeptidase inhibitor activity refers to the ability of a molecule to block or reduce the activity of endopeptidases, a class of enzymes that cleave peptide bonds within a protein or peptide chain. These inhibitors play crucial roles in regulating various cellular processes by controlling the activity of endopeptidases, which are involved in diverse functions such as protein degradation, signal transduction, and immune response.
**Mechanism of Action:**
Endopeptidase inhibitors can achieve their inhibitory effects through several mechanisms, including:
* **Competitive Inhibition:** The inhibitor binds to the active site of the endopeptidase, competing with the substrate for binding. This prevents the enzyme from cleaving the peptide bond.
* **Non-Competitive Inhibition:** The inhibitor binds to a site on the endopeptidase distinct from the active site, causing a conformational change that reduces the enzyme's activity.
* **Uncompetitive Inhibition:** The inhibitor binds to the enzyme-substrate complex, preventing the release of the products and effectively shutting down the enzyme's catalytic activity.
**Biological Significance:**
Endopeptidase inhibitors are involved in various biological processes, including:
* **Protein Degradation:** Inhibition of proteases, a type of endopeptidase, can prevent the breakdown of proteins, which is essential for maintaining cellular homeostasis and function.
* **Signal Transduction:** Endopeptidase inhibitors can modulate the activity of signaling pathways by regulating the processing and activation of signaling molecules.
* **Immune Response:** Inhibition of certain endopeptidases involved in immune responses can suppress inflammation or modulate the activity of immune cells.
* **Drug Development:** Endopeptidase inhibitors have potential therapeutic applications in treating various diseases, including cancer, cardiovascular disease, and inflammatory conditions.
**Examples of Endopeptidase Inhibitors:**
* **ACE inhibitors:** Inhibit angiotensin-converting enzyme (ACE), an endopeptidase involved in blood pressure regulation.
* **MMP inhibitors:** Inhibit matrix metalloproteinases (MMPs), endopeptidases involved in tissue remodeling and cancer metastasis.
* **Caspase inhibitors:** Inhibit caspases, endopeptidases involved in apoptosis (programmed cell death).
**Conclusion:**
Endopeptidase inhibitor activity is essential for regulating a wide range of cellular processes. These inhibitors play critical roles in maintaining cellular homeostasis, controlling signaling pathways, and modulating immune responses. Their potential therapeutic applications make them valuable targets for drug development.'
"
Protein | Definition | Taxonomy |
---|---|---|
Ubiquitin carboxyl-terminal hydrolase isozyme L5 | A ubiquitin carboxyl-terminal hydrolase isozyme L5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y5K5] | Homo sapiens (human) |
Complement C5 | A complement C5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P01031] | Homo sapiens (human) |
Complement C3 | A complement C3 that is encoded in the genome of human. [UniProtKB:P01024] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
carprofen | carprofen : Propanoic acid in which one of the methylene hydrogens is substituted by a 6-chloro-9H-carbazol-2-yl group. A non-steroidal anti-inflammatory drug, it is no longer used in human medicine but is still used for treatment of arthritis in elderly dogs. carprofen: RN given refers to cpd without isomeric designation | carbazoles; organochlorine compound | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug; photosensitizing agent |
oxaprozin | oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis. Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE. | 1,3-oxazoles; monocarboxylic acid | analgesic; non-steroidal anti-inflammatory drug |
raloxifene | raloxifene : A member of the class of 1-benzothiophenes that is 1-benzothiophene in which the hydrogens at positions 2, 3, and 6 have been replaced by p-hydroxyphenyl, p-[2-(piperidin-1-yl)ethoxy]benzoyl, and hydroxy groups, respectively. | 1-benzothiophenes; aromatic ketone; N-oxyethylpiperidine; phenols | bone density conservation agent; estrogen antagonist; estrogen receptor modulator |
tiaprofenic acid | tiaprofenic acid : An aromatic ketone that is thiophene substituted at C-2 by benzoyl and at C-4 by a 1-carboxyethyl group. tiaprofenic acid: RN given refers to parent cpd; structure | aromatic ketone; monocarboxylic acid; thiophenes | drug allergen; non-steroidal anti-inflammatory drug |
celastrol | monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory drug; antineoplastic agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Hsp90 inhibitor; metabolite | |
sulindac | sulindac : A monocarboxylic acid that is 1-benzylidene-1H-indene which is substituted at positions 2, 3, and 5 by methyl, carboxymethyl, and fluorine respectively, and in which the phenyl group of the benzylidene moiety is substituted at the para position by a methylsulfinyl group. It is a prodrug for the corresponding sulfide, a non-steroidal anti-inflammatory drug, used particularly in the treatment of acute and chronic inflammatory conditions. Sulindac: A sulfinylindene derivative prodrug whose sulfinyl moiety is converted in vivo to an active NSAID analgesic. Specifically, the prodrug is converted by liver enzymes to a sulfide which is excreted in the bile and then reabsorbed from the intestine. This helps to maintain constant blood levels with reduced gastrointestinal side effects. | monocarboxylic acid; organofluorine compound; sulfoxide | analgesic; antineoplastic agent; antipyretic; apoptosis inducer; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug; tocolytic agent |
acetyl isogambogic acid | acetyl isogambogic acid: structure in first source | ||
compstatin | compstatin: binds to complement 3; amino acid sequence in first source |